Concepedia

Ho H. Lee

HH

30

Publications

1.9K

Citations

23

H-Index

1976

Active since

Affiliations

University of Auckland(Current)

Cancer Society of New Zealand

Cleveland Clinic

University of California, Los Angeles

Pfizer (United States)

Ho H. Lee is an author at University of Auckland specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1976–2017

30

Publications

30

NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

Ho H. Lee, Hajir Dadgostar, Qingwen Cheng et al. · Proceedings of the National Academy of Sciences · 1999 · 515 citations

Inflammation and NO<sub>x</sub>-induced nitration: Assay for 3-nitrotyrosine by HPLC with electrochemical detection

Mark K. Shigenaga, Ho H. Lee, Benjamin C. Blount et al. · Proceedings of the National Academy of Sciences · 1997 · 171 citations · Full text

4-Phenylpyrrolo[3,4-<i>c</i>]carbazole-1,3(2<i>H</i>,6<i>H</i>)-dione Inhibitors of the Checkpoint Kinase Wee1. Structure−Activity Relationships for Chromophore Modification and Phenyl Ring Substitution

Brian D. Palmer, Andrew M. Thompson, R J Booth et al. · Journal of Medicinal Chemistry · 2006 · 107 citations · Full text

Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibition

Qingwen Cheng, Ho H. Lee, Ying Li et al. · Oncogene · 2000 · 105 citations

, , +11

Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-κB activation and intercellular adhesion molecule-1 up-regulation

Ho H. Lee, Paul W. Dempsey, Thomas P. Parks et al. · Proceedings of the National Academy of Sciences · 1999 · 86 citations · Full text

Rows per page

1–5 of 30